Bayer Signs $875 Million Deal to Buy Women’s Health Biotech

Bookmark
(Bloomberg) -- Bayer AG struck an $875 million deal to acquire British women’s health biotech Kandy Therapeutics Ltd., bolstering its pharmaceuticals division before patents expire on some key prod...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.